The Fezakinumab Biosimilar Anti-IL22 Antibody offered by Assay Genie is a cutting-edge tool for researchers studying the role of IL22 in immune regulation. This monoclonal antibody, developed through advanced technology, targets the IL22 protein with high specificity and sensitivity, allowing for precise detection and analysis in various experimental settings.IL22 is a key cytokine involved in the regulation of immune responses, particularly in the context of inflammation and tissue repair. By blocking the activity of IL22, researchers can gain valuable insights into its role in various disease states, including autoimmune disorders, inflammatory conditions, and cancer.
The Fezakinumab Biosimilar Anti-IL22 Antibody provides a reliable tool for investigating the mechanisms underlying IL22 signaling and its potential as a therapeutic target.With its proven effectiveness in research applications such as ELISA, Western blot, and immunohistochemistry, this antibody is a versatile tool for scientists studying immune regulation and seeking to develop novel therapeutic strategies. Trust Assay Genie's Fezakinumab Biosimilar Anti-IL22 Antibody to support your research endeavors and unlock new discoveries in the field of immunology.
Product Name:
Fezakinumab (Anti-IL22) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0096
Target:
IL22
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
ILV-094
Description:
Anti-IL22(fezakinumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
